AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development
Arev生命科學全球公司宣佈與TransBIOTech公司合作，促進臨牀前治療流水線的開發
VANCOUVER, BC / TheNewswire / April 21, 2022 / AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) ("AREV" or the "Company") AREV announced today its initial research engagement with TransBIOTech.
卑詩省温哥華/The Newswire/四月21, 2022 / Arev生命科學全球公司(CSE：ARREV)(場外交易代碼：AREVF)("阿雷夫“或 "公司") Arev今天宣佈其與TransBIOTech公司的初步研究合作。
Created in 1999, TransBIOTech, a publicly-supported preclinical research organization that works in partnership with and is supported by the Canadian government through the Natural Sciences and Engineering Research Council (NSERC) in collaboration with the Canadian Institutes of Health Research (CIHR). TransBIOTech is also supported by the Canadian Foundation for Innovation and by the Government of Quebec. TransBIOTech is a member of Tech-Access Canada, a national organization of Technology Access Centres (TACs) as well...
TransBIOTech成立於1999年，是一家公共支持的臨牀前研究組織，通過自然科學和工程研究理事會(NSERC)與加拿大衞生研究院(CIHR)合...
登入免費觀看全文
登入/註冊